Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest: Results of the thrombolysis in myocardial ischemia (TIMI IIIA) trial

Circulation

Volumn 87, Issue 1, 1993, Pages 38-52

  Braunwald, E ^a   Muller, J E ^a   McCabe, C H ^a   Knatterud, G L ^a   Thompson, B ^a   Prior, M J ^a   Terrin, M ^a   Canner, M ^a   Depkin, J ^a   Giro, R ^a   Kufera, J ^a   Monroe, W L ^a   Wilkins, P ^a   Solomon, R ^a   Colling, C ^a   Chaitman, B ^a   Shaw, L ^a   Wiens, R D ^a   Brown, B G ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

angina; arteriography, quantitative; myocardial infarction; non Q wave; plasminogen activators

Indexed keywords

ANTIANGINA PECTORIS AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEPARINIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBUS; UNSTABLE ANGINA PECTORIS;

EID: 0027396699     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.87.1.38     Document Type: Article

References (0)